Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

D HondaSponsor

74 cosponsors · 68 D, 6 R

11 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to develop, implement, and update a plan for the prevention, control, and medical management of hepatitis B and hepatitis C.

What it does: CRS summary · Introduced in House · Oct 29, 2009

Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), the Administrator of the Health Resources and Services Administration, and the Administrator of the Substance Abuse and Mental Health Services Administration (SAMHSA), to implement programs to increase awareness and enhance knowledge and understanding of hepatitis B and hepatitis C.

Requires the Secretary, acting through the Director of CDC, to: (1) support the integration of voluntary hepatitis B and hepatitis C testing programs into existing clinical and public health programs; (2) provide increased support to Adult Viral Hepatitis Coordinators to integrate prevention and control activities into existing health programs; (3) support the establishment of a hepatitis B and hepatitis C surveillance program; and (4) report on seroprevalence studies and the impact of hepatitis B and hepatitis C.

Directs the Secretary to support state, local, territorial, and tribal efforts to: (1) provide counseling and education on hepatitis B and hepatitis C; (2) expand the current vaccination programs for hepatitis B; and (3) provide referrals for treatment to individuals with hepatitis B or hepatitis C.

Requires the Secretary, acting through the Director of CDC, the Director of the National Cancer Institute, and the Director of the National Institutes of Health (NIH), to conduct research on hepatitis B and hepatitis C.

Authorizes the Secretary to award grants to, or enter into cooperative agreements with, governmental and nonprofit entities that have special expertise relating to hepatitis B and hepatitis C to support prevention activities.

Requires the Secretary, acting through the Administrator of SAMHSA, to develop educational materials and intervention strategies to reduce the risks of hepatitis among substance abusers and individuals with mental illness.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009

Latest action (Nov 2, 2009): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Oct 29, 2009

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.